Argenx
ARGX
#550
Rank
NZ$66.59 B
Marketcap
$1,114
Share price
0.90%
Change (1 day)
51.85%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company